WallStreetZenWallStreetZen

NASDAQ: CRVS
Corvus Pharmaceuticals Inc Earnings & Revenue

CRVS earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$30.2M
Current Profit Margin
0%

CRVS Return on Equity

Current Company
-60.8%
Current Industry
15.4%
Current Market
-8.4%
CRVS's Return on Equity (-60.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CRVS announces earnings.

CRVS Return on Assets

Current Company
-51.1%
Current Industry
2.2%
CRVS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CRVS Return on Capital Employed

Current Company
-67.63%
Current Industry
17.7%
CRVS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CRVS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CRVS$0.00-$29.98M-$30.19MN/AN/A
GTHX$77.89M-$56.61M-$70.74M+119.59%N/A
OTLK$0.00-$52.51M-$51.50M-100.00%N/A
GALT$0.00-$43.04M-$45.44MN/AN/A
CDXC$83.37M-$5.09M-$6.47M+22.66%N/A

CRVS earnings dates

Next earnings date
Mar 26, 2024

Corvus Pharmaceuticals Earnings & Revenue FAQ

What were CRVS's earnings last quarter?

On Invalid Date, Corvus Pharmaceuticals (NASDAQ: CRVS) reported Q3 2023 earnings per share (EPS) of -$0.12, up 62.5% year over year. Total Corvus Pharmaceuticals earnings for the quarter were -$6.00 million. In the same quarter last year, Corvus Pharmaceuticals's earnings per share (EPS) was -$0.32.

If you're new to stock investing, here's how to buy Corvus Pharmaceuticals stock.

What was CRVS's earnings growth in the past year?

As of Q1 2024, Corvus Pharmaceuticals's earnings has grown year over year. Corvus Pharmaceuticals's earnings in the past year totalled -$30.19 million.

What is CRVS's earnings date?

Corvus Pharmaceuticals's earnings date is Invalid Date. Add CRVS to your watchlist to be reminded of CRVS's next earnings announcement.

What was CRVS's revenue last quarter?

On Invalid Date, Corvus Pharmaceuticals (NASDAQ: CRVS) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Corvus Pharmaceuticals's revenue was $0.00.

What was CRVS's revenue growth in the past year?

As of Q1 2024, Corvus Pharmaceuticals's revenue has grown null year over year. Corvus Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.